EBIT (Quarterly)

EBIT: Income before interest and taxes.

Nutra Pharma Corp. (NPHC) had EBIT of $-0.38M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$0.05M
Net Income	$-0.46M
Cost of Goods Sold	$0.03M
Gross Profit	$0.02M
Operating Expenses	$0.43M
Operating Income	$-0.38M
Non-Operating Income/Expense	$-0.08M
Pre-Tax Income	$-0.46M
Normalized Pre-Tax Income	$-0.46M
Income after Taxes	$-0.46M
Income from Continuous Operations	$-0.46M
Consolidated Net Income/Loss	$-0.46M
Normalized Income after Taxes	$-0.46M
EBIT	$-0.38M
EBITDA	$-0.32M
Weighted-Average Shares Outstanding (Basic)	8.01B
Weighted-Average Shares Outstanding (Diluted)	8.01B
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$0.50M
Property, Plant, and Equipment	$0.02M
Long-Term Assets	$0.12M
Total Assets	$0.62M
Current Liabilities	$17.74M
Long-Term Debt	$0.14M
Long-Term Liabilities	$0.14M
Total Liabilities	$17.88M
Common Equity	$-17.27M
Tangible Shareholders Equity	$-17.26M
Shareholders Equity	$-17.26M
Common Shares Outstanding	7.16B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.33M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$0.34M
Beginning Cash	$0.01M
End Cash	$0.02M
Increase/Decrease in Cash	$0.01M
Stock-Based Compensation	$0.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.03
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.01
Debt to Equity Ratio	-0.58
Gross Margin	39.36%
Operating Margin	-786.60%
EBIT Margin	-786.60%
EBITDA Margin	--
Pre-Tax Profit Margin	-953.41%
Profit Margin	-953.41%
Free Cash Flow	$-0.33M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	1.24
Receiveable Turnover	0.13
Days Sales in Receivables	698.50
Return on Equity	2.66%
Return on Tangible Equity	2.66%
Return on Assets	-74.56%
Return on Investments	2.68%
Book Value Per Share	$-0.00
Free Cash Flow per Share	$0.00
Operating Cash Flow per Share	$0.00

Data from Zacks Investment Research, Inc.